Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01896700

Methylphenidate to Improve Balance and Walking in MS

Sponsor: Oregon Health and Science University

Updated 7 times since 2017 Last updated: Mar 8, 2018 Started: Jul 31, 2013 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Multiple Sclerosis, this trial is completed. The trial is conducted by Oregon Health and Science University and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
May 2018 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Feb 2017 — May 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oregon Health and Science University
Portland VA Medical Center

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States